Disease stage related in vitro responsiveness of peripheral blood T-lymphocytes in patients with head and neck carcinoma

被引:8
作者
Heimdal, JH
Aarstad, HJ [1 ]
Klementsen, B
Olofsson, J
机构
[1] Haukeland Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, N-5021 Bergen, Norway
[2] Univ Bergen, Broegelmann Res Lab Microbiol, Bergen, Norway
关键词
IL-2; IL-4; squamous cell carcinoma; TNM stage; T lymphocytes;
D O I
10.1080/00016489850182639
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 [耳鼻咽喉科学];
摘要
The in vitro responsiveness of peripheral blood mononuclear cells (PBMC) T lymphocytes was studied in 81 patients with limited or extended head and neck squamous cell carcinoma (HNSCC), as judged by T, N and T + N stages. Patients included in the study were males below 80 years of age, without auto-immune disease or cachexia, who were not taking any immune-active medication at the time of diagnosis. The patients were divided into groups according to TNM stage T0-2 vs T3-4, N0-1 vs N2-3 or T + N0-3 vs T + N4-7. When cells from patients with early and late stage, according to T, N or T + N stage, were compared, we found a decreased level of mitogen stimulated T-cells and decreased spontaneous proliferation with increasing disease stage. The same was true if the in vitro mitogenesis of T-cells was analysed separately, depending on the laryngeal or oral cavity/pharyngeal origin of the patients' tumours. If the patients were divided into two groups based on N stage, decreased gamma-interferon, and to some extent interleukin (IL-2), but not IL-4 levels, were found to be related to the disease stage.
引用
收藏
页码:887 / 891
页数:5
相关论文
共 19 条
[1]
[Anonymous], 1992, TNM classification of malignant tumors
[2]
Enhanced generation of interleukins 1 beta and 6 may contribute to the cachexia of chronic disease [J].
Cederholm, T ;
Wretlind, B ;
Hellstrom, K ;
Andersson, B ;
Engstrom, L ;
Brismar, K ;
Scheynius, A ;
Forslid, J ;
Palmblad, J .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1997, 65 (03) :876-882
[3]
DETECTION OF REGULATORY FACTORS OF LYMPHOKINE-ACTIVATED KILLER-CELL ACTIVITY IN HEAD AND NECK-CANCER PATIENTS TREATED WITH INTERLEUKIN-2 AND INTERFERON-ALPHA [J].
CLAYMAN, GL ;
SAVAGE, HE ;
YOUNG, G ;
LAVEDAN, P ;
TAYLOR, DL ;
SCHANTZ, SP .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1992, 101 (11) :909-915
[5]
FUNCTIONAL AND PHENOTYPIC ANALYSIS OF T-LYMPHOCYTES IN LARYNGEAL CARCINOMA [J].
GONZALEZ, FM ;
VARGAS, JA ;
GEABANACLOCHE, JC ;
GARCIA, JR ;
BERROCAL, E ;
GORRIZ, C ;
DURANTEZ, A .
ACTA OTO-LARYNGOLOGICA, 1994, 114 (06) :663-668
[6]
GRANDIS JR, 1992, CANCER, V70, P2166, DOI 10.1002/1097-0142(19921015)70:8<2166::AID-CNCR2820700826>3.0.CO
[7]
2-H
[8]
In vitro T-lymphocyte function in head and neck cancer patients [J].
Heimdal, JH ;
Aarstad, HJ ;
Aakvaag, A ;
Olofsson, J .
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 1997, 254 (07) :318-322
[9]
HIRABAYASHI H, 1995, ARCH OTOLARYNGOL, V121, P285
[10]
ROLE OF CENTRAL-NERVOUS-SYSTEM AND BEHAVIOR IN THE IMMUNE-RESPONSE [J].
HUSBAND, AJ .
VACCINE, 1993, 11 (08) :805-816